|
|
|
Opportunity assessment/strategy development
- New products (including demand sensitivities)
- Qualitative and quantitative study
to understand the opportunity for two
ADHD medications in a developed US market and in small EU markets
- Demand sensitivity
for several diabetes treatments, including by patient
type, order of entry, and source of share (new demand versus share replacement from which product)
- Opportunity assessment by decision point
- revenue from initiatives
aimed at generating additional care seeking, improved diagnosis, enhanced dosing, increased patient
acceptance of medication, better compliance, etc. - for a neuropathic pain agent
- Demand sensitivity
for an osteoporosis medication
- Market dynamics (new studies / indications, new competitors, competitive assessments, etc.)
- Impact of new entrants and new data
on an
existing cardiovascular medication and impact of
messages / initiatives to prevent share loss
- Impact of new entrants on a diabetes medication
Customer groups / markets
- Opportunity for an existing product with physicians assistants and nurse practitioners
- Opportunity for a pain medication in 18 different specialties and across several settings
(including office practices, hospitals, home health, nursing homes)
Buying Process / patient flow / landscape studies
Segmentation and strategic targeting
- Segmentation and targeting of physicians and consumers for an obesity medication based on their
propensity to use different products and other characteristics
- Segmentation of physicians and sufferers for a pain medication based on the characteristics that
are most likely to influence their purchasing behavior
Positioning / message development
- Positioning (repositioning) and message development for the world's largest medication given new
clinical data and entry of competitors
- Platform development and testing for a diabetes medication
Qualitative research
- Multi-country qualitative research in sleep disorders
- Qualitative research to understand drivers of prescribing in a complex category
- Qualitative research to determine impact of payors on prescribing in a cardiovascular condition
Global research
- 10 market qualitative and quantitative study
|
|
|